Tenascin-C as a cardiovascular marker
Novel biological markers, such as fibrosis marker galectin-3, peptide hormone adrenomedullin, soluble ST2, chemokine CX3CL1, surrogate marker of vasopressin, and others, are every year one step closer to being introduced into health practice. Over the past decades, significant progress has been made...
Main Authors: | A. M. Alieva, A. V. Sozykin, N. V. Teplova, E. V. Reznik, D. V. Izimarieva, N. A. Novikova, I. V. Lozovsky, Е. E. Averin, R. K. Valiev, I. G. Nikitin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2022-09-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5150 |
Similar Items
-
Tenascin-C in Heart Diseases—The Role of Inflammation
by: Kyoko Imanaka-Yoshida
Published: (2021-05-01) -
The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases
by: Ken-ichi Matsumoto, et al.
Published: (2020-12-01) -
A model for prognosis of development of left ventricular systolic dysfunction in patients with acute myocardial infarction and type 2 diabetes mellitus taking into account tenascin C level
by: M. Yu. Koteliukh
Published: (2016-03-01) -
Editorial: Tenascins – Key Players in Tissue Homeostasis and Defense
by: Kyoko Imanaka Yoshida, et al.
Published: (2022-01-01) -
Early Days of Tenascin-R Research: Two Approaches Discovered and Shed Light on Tenascin-R
by: Fritz G. Rathjen, et al.
Published: (2021-01-01)